Large gap with delayed quotes
Analysis date: 14.04.2026
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 14.04.2026.
Interest
Strong
Strong
Three stars since 14.04.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 06.03.2026 at a price of 83.60.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 10.04.2026.
4wk Rel Perf
4.98%
4.98%
The four-week dividend-adjusted overperformance versus STOXX600 is 4.98%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 26.08.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 1.89%.
Mkt Cap in $bn
4.03
4.03
With a market capitalization between $2 & $8bn, WENDEL is considered a mid-cap stock.
G/PE Ratio
0.61
0.61
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
29.61
29.61
The estimated PE is for the year 2027.
LT Growth
11.20%
11.20%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
5
5
Over the last seven weeks, an average of 5 analysts provided earnings per share estimates.
Dividend Yield
6.78%
6.78%
The earnings forecasts are not sufficient to cover the twelve month estimated dividend.
Beta
111
111
For 1% of index variation, the stock varies on average by 1.11%.
Correlation
0.56
0.56
55.65% of stock movements are explained by index variations.
Value at Risk
10.23
10.23
The value at risk is estimated at EUR 10.23. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.02.2002
27.02.2002